Xuebijing injection reduces 28-day mortality in patients with septic shock

Crit Care. 2025 Oct 6;29(1):419. doi: 10.1186/s13054-025-05666-3.

Jing Kang^#¹, Dingji Hu^#², Yixuan Li^#³, Lufeng Ma⁴, Hui Chen², Jianfeng Xie², Yi Yang², Tianyi Yang⁵, Zhiqiao Feng⁴, Yan Liu¹, Haibo Qiu², Songqiao Liu^{6

7}, Chi Zhang^{8

9}

¹ Dongzhimen Hospital, Beijing University of Chinese Medicine, Dongcheng District, 100010, Beijing, China.
² Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Jiangsu, 210009, Nanjing, China.
³ School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong, China.
⁴ Tianjin Chasesun Pharmaceutical Co., Ltd., Wuqing Development Zone, 301700, Tianjin, China.
⁵ Institute for Health, Health Care Policy and Aging Research, Rutgers, The State University of New Jersey, New Jersey, NJ 08901, New Brunswick, United States.
⁶ Jiangsu Provincial Key Laboratory of Critical Care Medicine, Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Jiangsu, 210009, Nanjing, China. liusongqiao@ymail.com.
⁷ The First People's Hospital of Lianyungang, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Jiangsu, 222000, Lianyungang, China. liusongqiao@ymail.com.
⁸ Dongzhimen Hospital, Beijing University of Chinese Medicine, Dongcheng District, 100010, Beijing, China. saga618@126.com.
⁹ Institute for Brain Disorders, Beijing University of Chinese Medicine, Dongcheng District, 100010, Beijing, China. saga618@126.com.

^# Contributed equally.

No abstract available

Publication types